Skip to content

Self Monitoring Device Fortrasvaginal Ultrasound in Reproduction

Self Monitoring Device (SMD) for Trasvaginal Ultrasound in Reproduction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05180019
Acronym
AUTOECOSMD
Enrollment
101
Registered
2022-01-06
Start date
2022-02-09
Completion date
2023-05-08
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-Evaluation

Keywords

Trasvaginal ultrasound 3D, Self-Monitoring Device, Pelvic ultrasound volume, risks, Trasvaginal ultrasound 2D

Brief summary

Serial ultrasound (US) examinations are performed to assess the number and size of follicles during controlled ovarian stimulation (COS). Ovarian folliculometry during COS is the most frequent ultrasound procedure daily performed, an also a highly time consuming and reiterative process. However, it has been shown that manual measurement of follicles with 2D US is often inaccurate and subject to significant intra- and interobserver variability In addition, a follicle is a three-dimensional (3D) structure and its volume is the most accurate measure of its size. Therefore, 3D transvaginal ultrasound in gynaecology and reproductive medicine has supposed a great advance, because it makes possible to obtain ovarian volumes during controlled ovarian stimulation

Detailed description

At each visit, IVIRMA Bilbao doctors (MF, CF) will perform routine folliculometry to the patients (standard 2D manual ultrasound) to control the ovarian stimulation. In this exam, follicles will be counted and measured (mean diameter) in millimeters, as usual clinical practice, After the standard folliculometry, will request the patient for self-performing scan (3Dultrasound) After each patient self-capture, IVIRMA Bilbao gynaecologists will check the saved volume (3D multiplanar mode) using ITKSnap viewer to ensure the correct acquisition saving (complete ovaries and uterus captured inside without artifacts) in order to compare 2D ultrasound (clinical reference) for number and mean follicle diameter estimations, with 3D multiplanar ultrasound (obtained with SMD) GMDN (Global Medical Device Nomenclature): 40761

Interventions

DEVICESMD ( Self Monitoring Device)

Automated 3D ultrasound based follicullometry with SMD self-performed by the patient.

Sponsors

IVI Bilbao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

1. Informed consent form dated and signed 2. Female, aged 18 years or above 3. Patient undergoing COS for IVF/ICSI, oocyte vitrification or oocyte donation cycles in IVIRMA Bilbao clinic 4. Willing to comply with all study requirements

Exclusion criteria

1. Simultaneous participation in another clinical study that, at researcher's criteria, could interfere with the results of this study. 2. Any significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
SMD validation for clinical useThree monthsAfter the standard folliculometry, will request the patient for self-performing scan (3D ultrasound)
Determination of the risks during use SMDThree monthsPatients will have phone connection to call the nurse if any problems happen or when they finish the scan.

Secondary

MeasureTime frameDescription
Patient's perception as a user of the SMDThree monthsTo know the patient's perception as a user of the SMD by means of a satisfaction questionnaire
To recopilate the pelvic ultrasound volumesThree monthsTo recopilate the pelvic ultrasound volumes (uterus and ovaries inside) during COS exams for posterior development of an automated segmentation system (of the uterus and the ovaries) in the context of a next project, conditioned to the obtention of satisfactory outcomes after the finalization of the present study.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026